325 related articles for article (PubMed ID: 21029005)
21. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns.
Hussein K; Sprecher H; Mashiach T; Oren I; Kassis I; Finkelstein R
Infect Control Hosp Epidemiol; 2009 Jul; 30(7):666-71. PubMed ID: 19496647
[TBL] [Abstract][Full Text] [Related]
22. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.
Bhargava A; Hayakawa K; Silverman E; Haider S; Alluri KC; Datla S; Diviti S; Kuchipudi V; Muppavarapu KS; Lephart PR; Marchaim D; Kaye KS
Infect Control Hosp Epidemiol; 2014 Apr; 35(4):398-405. PubMed ID: 24602945
[TBL] [Abstract][Full Text] [Related]
24. Which proportion of extended-spectrum beta-lactamase producing strains could be treated by non-carbapenem beta-lactams?
Canoui E; Tankovic J; Bige N; Alves M; Offenstadt G
Med Mal Infect; 2014 May; 44(5):235-7. PubMed ID: 24780641
[No Abstract] [Full Text] [Related]
25. Changes in antibiotic usage and susceptibility in nosocomial Enterobacteriaceae and Pseudomonas isolates following the introduction of ertapenem to hospital formulary.
Graber CJ; Hutchings C; Dong F; Lee W; Chung JK; Tran T
Epidemiol Infect; 2012 Jan; 140(1):115-25. PubMed ID: 21303590
[TBL] [Abstract][Full Text] [Related]
26. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
27. Multicenter Study of the Risk Factors for Colonization or Infection with Carbapenem-Resistant Enterobacteriaceae in Children.
Chiotos K; Tamma PD; Flett KB; Naumann M; Karandikar MV; Bilker WB; Zaoutis T; Han JH
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971864
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for KPC-producing Enterobacteriaceae acquisition and infection in a healthcare setting with possible local transmission: a case-control study.
Cronin KM; Poy Lorenzo YS; Olenski ME; Bloch AE; Visvanathan K; Waters MJ; Buising KL
J Hosp Infect; 2017 Jun; 96(2):111-115. PubMed ID: 28389093
[TBL] [Abstract][Full Text] [Related]
29. Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
Lee M; Chung HS
J Microbiol Methods; 2015 May; 112():87-91. PubMed ID: 25794901
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity.
Swaminathan M; Sharma S; Poliansky Blash S; Patel G; Banach DB; Phillips M; LaBombardi V; Anderson KF; Kitchel B; Srinivasan A; Calfee DP
Infect Control Hosp Epidemiol; 2013 Aug; 34(8):809-17. PubMed ID: 23838221
[TBL] [Abstract][Full Text] [Related]
31. Statewide surveillance of carbapenem-resistant enterobacteriaceae in Michigan.
Brennan BM; Coyle JR; Marchaim D; Pogue JM; Boehme M; Finks J; Malani AN; VerLee KE; Buckley BO; Mollon N; Sundin DR; Washer LL; Kaye KS
Infect Control Hosp Epidemiol; 2014 Apr; 35(4):342-9. PubMed ID: 24602937
[TBL] [Abstract][Full Text] [Related]
32. Fecal carriage of carbapenem-resistant Enterobacteriaceae in a Chinese university hospital.
Zhao ZC; Xu XH; Liu MB; Wu J; Lin J; Li B
Am J Infect Control; 2014 May; 42(5):e61-4. PubMed ID: 24773806
[TBL] [Abstract][Full Text] [Related]
33. Carbapenem-resistant strains from the family Enterobacteriaceae isolated in the period 2006-2011 from clinical specimens of patients treated at the university hospital in northeastern Poland.
Michalska AD; Sacha PT; Ojdana D; Majewski P; Wieczorek P; Tryniszewska E
Med Dosw Mikrobiol; 2013; 65(1):27-38. PubMed ID: 24180129
[TBL] [Abstract][Full Text] [Related]
34. Active case finding for carbapenemase-producing Enterobacteriaceae in a teaching hospital: prevalence and risk factors for colonization.
Poole K; George R; Decraene V; Shankar K; Cawthorne J; Savage N; Welfare W; Dodgson A
J Hosp Infect; 2016 Oct; 94(2):125-9. PubMed ID: 27542962
[TBL] [Abstract][Full Text] [Related]
35. Molecular and descriptive epidemiologyof multidrug-resistant Enterobacteriaceae in hospitalized infants.
Anderson B; Nicholas S; Sprague B; Campos J; Short B; Singh N
Infect Control Hosp Epidemiol; 2008 Mar; 29(3):250-5. PubMed ID: 18251685
[TBL] [Abstract][Full Text] [Related]
36. Emergence and risk factors of β-lactamase-mediated resistance to oxyimino-β-lactams in Enterobacteriaceae isolates.
Manageiro V; Ferreira E; Jones-Dias D; Louro D; Pinto M; Diogo J; Caniça M
Diagn Microbiol Infect Dis; 2012 Mar; 72(3):272-7. PubMed ID: 22209509
[TBL] [Abstract][Full Text] [Related]
37. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
38. Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora.
Crémet L; Bourigault C; Lepelletier D; Guillouzouic A; Juvin ME; Reynaud A; Corvec S; Caroff N
J Antimicrob Chemother; 2012 Apr; 67(4):1041-3. PubMed ID: 22223227
[No Abstract] [Full Text] [Related]
39. Clinical features of patients with carbapenem nonsusceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan.
Chang YY; Chuang YC; Siu LK; Wu TL; Lin JC; Lu PL; Wang JT; Wang LS; Lin YT; Huang LJ; Fung CP
J Microbiol Immunol Infect; 2015 Apr; 48(2):219-25. PubMed ID: 25074627
[TBL] [Abstract][Full Text] [Related]
40. Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes.
Mouloudi E; Protonotariou E; Zagorianou A; Iosifidis E; Karapanagiotou A; Giasnetsova T; Tsioka A; Roilides E; Sofianou D; Gritsi-Gerogianni N
Infect Control Hosp Epidemiol; 2010 Dec; 31(12):1250-6. PubMed ID: 20973725
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
